MATINAS BIOPHARMA HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 11.26 million shares for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 0.00 shares.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 0.00 shares.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-06-30 was 5.63M shares.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-03-31 was 5.63M shares.
- MATINAS BIOPHARMA HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 666.67K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-13 | 5.63M shares derived: sum of 3 quarters · filed 2026-08-13 | 11.26M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 5.63M shares derived: sum of 2 quarters · filed 2025-11-10 | 11.26M shares 10-Q · filed 2025-11-10 | 11.26M shares derived: sum of 4 quarters · filed 2026-03-31 | |
| 2025-06-30 | 5.63M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 11.26M shares 10-Q · filed 2025-08-14 | 11.26M shares derived: sum of 3 quarters · filed 2026-03-31 | 11.26M shares derived: sum of 4 quarters · filed 2026-03-31 | |
| 2025-03-31 | 5.63M shares 10-Q · filed 2025-05-15 | 5.63M shares derived: sum of 2 quarters · filed 2026-03-31 | 5.63M shares derived: sum of 3 quarters · filed 2026-03-31 | ||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-31 | 666.67K shares 10-K · filed 2026-03-31 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 666.67K shares 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 666.67K shares 10-Q · filed 2025-08-14 | 33.33M shares 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |